Thank you.
First, thanks to everybody for coming. We are scrambling a bit. We also found out about this late in the game.
I want to talk about timing. When we found out... After November 23 we went into the holiday season. When we came back and had to get to work as a committee, we sent in a letter to ask if we could get an extension. We were able to get 30 days. Then we had a motion to do this study to try to get some of the testimony forward that could have been involved previously. As other witnesses have said, that wasn't part of the process this time.
In January, a study came out of Europe from the HFFA. Are you familiar with that two-year study on...? It wasn't specifically on imidacloprid but it was to do with neonics. If any of you have read that study—it came out January 2017—do you any comments on the findings? No?